logo-loader
ASX:AVR NASDAQ:AVR

Anteris Technologies Global Corp

Receive alerts
Market:
ASX
Price
5.41 AUD
Day Change
-7.68%
Market Cap:
$201.77 m
52 weeks high
20.00
52 weeks low
4.26

In brief

Anteris Technologies Ltd is a structural heart company committed to designing, developing, and commercialising innovative medical devices.

Founded in Australia, with a significant presence in Minneapolis, USA (a MedTech hub), Anteris is science-driven, with an experienced team of multidisciplinary professionals delivering transformative solutions to structural heart disease patients. The company’s lead product, DurAVRTM, is a transcatheter heart valve (THV) for treating aortic stenosis. 

Snapshot

  • Anteris scales for pivotal PARADIGM Trial, plunging R&D investment into clinical activities
  • Anteris Technologies' ADAPT® conduit proof of concept animal study finds no calcification in carotid artery
  • Anteris Technologies and v2vmedtech achieve concept lock for new TEER system
OSZAR »